1. 1344. Ridinilazole (RDZ) for Clostridium difficile Infection (CDI): Impact of Diagnostic Method on Outcomes From a Phase 2 Clinical Trial. (26th November 2018) Authors: Vickers, Richard; Chowdhury, Sumita; Wilcox, Mark Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1361. Pharmacokinetics and Safety of Ridinilazole (RDZ), a Potential New Therapy for Clostridium difficile Infection (CDI): From Animal Models to Patients. (26th November 2018) Authors: Duperchy, Esther; Chowdhury, Sumita; Vickers, Richard; Robinson, Neil Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1369. Combined Analysis of the In Vitro Activity of Ridinilazole (RDZ) Against More Than 500 Clostridium difficile (CD) Clinical Isolates and Impact of RDZ on Cell Morphology. (26th November 2018) Authors: Duperchy, Esther; Bassères, Eugénie; Garey, Kevin; Vickers, Richard Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1774. Ridinilazole (RDZ) for Clostridium difficile infection (CDI): Correlation of In Vitro Spectrum of Activity with Human Gut Microbiome Profiles from a Phase 2 Clinical Trial. (26th November 2018) Authors: Vickers, Richard; Goldstein, Ellie J C; Citron, Diane; Snydman, David; Thorpe, Cheleste M; Kane, Anne V Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2387. Selecting Clostridium difficile Infection (CDI) Outcome Measures Relevant to Public Health Concerns: Experience From a Ridinilazole (RDZ) Phase 2 Trial. (26th November 2018) Authors: Vickers, Richard; Chowdhury, Sumita Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Imaging-based chemical screens using normal and glioma-derived neural stem cells. (26th July 2010) Authors: Danovi, Davide; Falk, Anna; Humphreys, Peter; Vickers, Richard; Tinsley, Jon; Smith, Austin G.; Pollard, Steven M. Journal: Biochemical Society transactions Issue: Volume 38:Number 4(2010) Page Start: 1067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mobile media, participation culture and the digital vernacular: 24-hours.in and the democratization of documentary. Issue 1 (1st October 2013) Authors: Vickers, Richard Journal: Ubiquity Issue: Volume 2:Issue 1/2(2013) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Preservation of Gut Microbiome Following Ridinilazole vs. Fidaxomicin Treatment of Clostridium difficile Infection. (4th October 2017) Authors: Mitra, Suparna; Chilton, Caroline; Freeman, Jane; Wood, Henry; Quirke, Phil; Taylor, Morag; Vickers, Richard; Wilcox, Mark Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The discovery of a novel antibiotic for the treatment of Clostridium difficile infections: a story of an effective academic–industrial partnership. Issue 8 (5th August 2015) Authors: Mann, John; Taylor, Peter W.; Dorgan, Colin R.; Johnson, Peter D.; Wilson, Francis X.; Vickers, Richard; Dale, Aaron G; Neidle, Stephen Journal: MedChemComm Issue: Volume 6:Issue 8(2015:Aug.) Page Start: 1420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Utilizing graph machine learning within drug discovery and development. Issue 6 (19th May 2021) Authors: Gaudelet, Thomas; Day, Ben; Jamasb, Arian R; Soman, Jyothish; Regep, Cristian; Liu, Gertrude; Hayter, Jeremy B R; Vickers, Richard; Roberts, Charles; Tang, Jian; Roblin, David; Blundell, Tom L; Bronstein, Michael M; Taylor-King, Jake P Journal: Briefings in bioinformatics Issue: Volume 22:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗